Research and experimentation tax incentives and international tax issues, including:
Administration's FY 2014 corporate tax proposals,
Tax Reform, including House Ways and Means Discussion Draft Implementation of PL 112-029, the American Invents Act
Trans-Pacific Partnership - 12 years of data exclusivity
ITC (International Trade Commission)Patent Reform, no specific bill S.957, The Drug Supply Chain Security Act (Track and Trace)
S.959, The Pharmaceutical Quality Security and Accountability Act (Track and Trace; Compounding)
H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013 (Track and Trace)
S.3187, The Food and Drug Safety and Innovation Act (Prescription Drug User Fee Act Reauthorization; Track and Trace)Biosimilars, no specific bill
Health Resources and Services Administration policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill End Stage Renal Disease and issues related to dialysis
Medicare Part B drug reimbursement issues (Average Sales Price)
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
NANCY ELLEN MCCARTHY L NICOLE CURRIE VICTORIA BLATTER HELEN RHEE WILLIAM O'BRIEN WILLIAM O'BRIEN HELEN RHEE GREGORY PORTNER L NICOLE CURRIE GREGORY PORTNER HELEN RHEE CHAKA BURGESS REBECCA MANDELL HOWARD MOON JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN